A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genome

Schweitzer, 2015, Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013, Lancet, 386, 1546, 10.1016/S0140-6736(15)61412-X Nassal, 2015, HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B, Gut, 64, 1972, 10.1136/gutjnl-2015-309809 Reaiche, 2010, The persistence in the liver of residual duck hepatitis B virus covalently closed circular DNA is not dependent upon new viral DNA synthesis, Virology, 406, 286, 10.1016/j.virol.2010.07.013 Watashi, 2014, NTCP and beyond: opening the door to unveil hepatitis b virus entry, Int J Mol Sci, 15, 2892, 10.3390/ijms15022892 Li, 2014, HBV life cycle is restricted in mouse hepatocytes expressing human NTCP, Cell Mol Immunol, 11, 175, 10.1038/cmi.2013.66 Lempp, 2016, Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor, J Hepatol, 64, 556, 10.1016/j.jhep.2015.10.030 Bissig, 2010, Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment, J Clin Invest, 120, 924, 10.1172/JCI40094 Huang, 2012, Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice, Gastroenterology, 142, 1447, 10.1053/j.gastro.2012.03.006 Dion, 2013, Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules, J Virol, 87, 5554, 10.1128/JVI.03134-12 Yang, 2002, Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection, Proc Natl Acad Sci U S A, 99, 13825, 10.1073/pnas.202398599 Guidotti, 1995, High-level hepatitis B virus replication in transgenic mice, J Virol, 69, 6158, 10.1128/JVI.69.10.6158-6169.1995 Buchmann, 2013, A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice, Vaccine, 31, 1197, 10.1016/j.vaccine.2012.12.074 Hong, 2011, Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice, Vaccine, 29, 3909, 10.1016/j.vaccine.2011.03.025 Dembek, 2015, Mouse models for therapeutic vaccination against hepatitis B virus, Med Microbiol Immunol, 204, 95, 10.1007/s00430-014-0378-6 Soriano, 1999, Generalized lacZ expression with the ROSA26 Cre reporter strain, Nat Genet, 21, 70, 10.1038/5007 Pettitt, 2009, Agouti C57BL/6N embryonic stem cells for mouse genetic resources, Nat Methods, 6, 493, 10.1038/nmeth.1342 Farley, 2000, Widespread recombinase expression using FLPeR (flipper) mice, Genesis, 28, 106, 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T Muzumdar, 2007, A global double-fluorescent Cre reporter mouse, Genesis, 45, 593, 10.1002/dvg.20335 Postic, 2000, DNA excision in liver by an albumin-Cre transgene occurs progressively with age, Genesis, 26, 149, 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V Ventura, 2007, Restoration of p53 function leads to tumour regression in vivo, Nature, 445, 661, 10.1038/nature05541 Liu, 1999, Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA, Gene Ther, 6, 1258, 10.1038/sj.gt.3300947 Cudré-Mauroux, 2003, Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a Duchenne myoblast cell line with long-term genotypic and phenotypic stability, Hum Gene Ther, 14, 1525, 10.1089/104303403322495034 Billioud, 2016, In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides, J Hepatol, 64, 781, 10.1016/j.jhep.2015.11.032 Tang, 2005, The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication, J Virol, 79, 5548, 10.1128/JVI.79.9.5548-5556.2005 Gilbert, 2000, The hepatitis B virus core promoter is strongly activated by the liver nuclear receptor fetoprotein transcription factor or by ectopically expressed steroidogenic factor 1, J Virol, 74, 5032, 10.1128/JVI.74.11.5032-5039.2000 Kruse, 2020, Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection, Virus Res, 292, 198224, 10.1016/j.virusres.2020.198224 Decorsière, 2016, Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor, Nature, 531, 386, 10.1038/nature17170 Chen, 2011, A comparison of exogenous promoter activity at the ROSA26 locus using a ΦiC31 integrase mediated cassette exchange approach in mouse ES cells, PLoS One, 6 Pham, 1996, Long-range disruption of gene expression by a selectable marker cassette, Proc Natl Acad Sci U S A, 93, 13090, 10.1073/pnas.93.23.13090 Zhu, 2006, Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase, FEBS Lett, 580, 4346, 10.1016/j.febslet.2006.06.094 Gao, 2007, Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein, J Virol, 81, 6164, 10.1128/JVI.02721-06 Qi, 2016, DNA polymerase κ is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus, Plos Pathog, 12, 10.1371/journal.ppat.1005893 Ray, 2000, The Cre-loxP system: a versatile tool for targeting genes in a cell- and stage-specific manner, Cel Transpl, 9, 805, 10.1177/096368970000900607 Wang, 2012, Hepatic gene transfer in neonatal mice by adeno-associated virus serotype 8 vector, Hum Gene Ther, 23, 533, 10.1089/hum.2011.183 Zhang, 1996, Inducible site-directed recombination in mouse embryonic stem cells, Nucl Acids Res, 24, 543, 10.1093/nar/24.4.543 Fang, 1994, Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer, Gene Ther, 1, 247 Smith, 1993, Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice, Nat Genet, 5, 397, 10.1038/ng1293-397 Zhu, 2007, Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways, J Virol, 81, 3170, 10.1128/JVI.02192-06 Cavanaugh, 1998, Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice, J Virol, 72, 2630, 10.1128/JVI.72.4.2630-2637.1998 Li, 2018, Recombinant covalently closed circular DNA of hepatitis B virus induces long-term viral persistence with chronic hepatitis in a mouse model, Hepatology, 67, 56, 10.1002/hep.29406 Yan, 2017, HBVcircle: a novel tool to investigate hepatitis B virus covalently closed circular DNA, J Hepatol, 66, 1149, 10.1016/j.jhep.2017.02.004 Qi, 2014, Recombinant covalently closed circular hepatitis B virus DNA induces prolonged viral persistence in immunocompetent mice, J Virol, 88, 8045, 10.1128/JVI.01024-14 Guo, 2016, The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely, Sci Rep, 6, 25552, 10.1038/srep25552 Wu, 2018, Establishment of Cre-mediated HBV recombinant cccDNA (rcccDNA) cell line for cccDNA biology and antiviral screening assays, Antivir Res, 152, 45, 10.1016/j.antiviral.2018.02.007 Graumann, 2015, Genomic methylation inhibits expression of hepatitis B virus envelope protein in transgenic mice: a non-infectious mouse model to study silencing of HBV surface antigen genes, PLoS One, 10, 10.1371/journal.pone.0146099 Chen, 2012, Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors, PLoS One, 7 Yang, 2014, A mouse model for HBV immunotolerance and immunotherapy, Cel Mol Immunol, 11, 71, 10.1038/cmi.2013.43